Metastatic Tumor Research and Outcomes Network

Overview

About this study

The registry aims to collect patient information such as patient demographics, co-morbidities, clinical, diagnostic, and therapeutic data, as well as information on adverse events and HRQOL outcomes specific for patients with metastatic spine tumor(s).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria: -Patient 18 or older. -Patient diagnosed with a metastatic tumor of the spine -Informed consent obtained, i.e.: -Ability to understand the content of the patient information/ICF -Willingness and ability to participate in the registry according to the Registry Plan -Signed and dated EC/IRB approved written informed consent (if consent is required by the EC/ IRB at the registry site) Exclusion Criteria: • Patient diagnosed with a primary tumor of the spine.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Michelle Clarke, M.D.	Open for enrollment	Contact information: Sandra Twaites (507) 284-5775 Twaites.Sandra@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Michelle Clarke, M.D.

Open for enrollment

Contact information:

Sandra Twaites

(507) 284-5775

Twaites.Sandra@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials